New grad roles at Dianthus Therapeutics
Dianthus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for severe autoimmune diseases. Its pipeline includes claseprubart, a selective active C1s complement inhibitor, and DNTH212, a bifunctional protein targeting Type 1 interferon and B-cell pathways.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 4
No current roles
Clear a filter to see every role.
Get new Dianthus Therapeutics new grad roles by email
Free account. Get new Dianthus Therapeutics new grad roles by email or push the minute they post.
